Text Size

Eyedrops containing SA9000 prodrugs result in sustained reductions in intraocular pressure in rabbits

Arnold J.J., Choksi Y., Chen X., Shimazaki A., Hatten J., Toone E.J., Epstein D.L., Challa P.


  • 2009
  • Journal of Ocular Pharmacology and Therapeutics
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Preclinical development

  • Affiliations

    Department of Ophthalmology, Duke University School of Medicine, Duke University, Durham, NC, United States; Department of Chemistry, Duke University School of Medicine, Duke University, Durham, NC, United States; Santen Pharmaceutical Co Ltd., Tokyo, Japan; Department of Pharmaceutical, Social, and Administrative Sciences, Samford University McWhorter School of Pharmacy, Birmingham, AL, United States; Duke Eye Center, Box 3802 DUMC, Durham, NC 27710, United States

Related Publications

Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: 2-year Results from a Randomized, Multicenter Study

Panarelli JF, Moster MR, Garcia-Feijoo J, Flowers BE, Baker ND, Barnebey HS, Grover DS, Khatana AK, Lee B, Nguyen T, Stiles MC, Sadruddin O, Khaw PT.


Omidenepag Isopropyl in Latanoprost Low/Non-Responders with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3, Non-Randomized, Two-Phase, Open-Label Study

Panarelli JF, Bowden EC, Tepedino ME, Odani-Kawabata N, Pei Z, McLaurin EB, Ropo A.


The Development of a SIBS Shunt to Treat Glaucoma

Pinchuk L.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022